Article
[Clinical Value of Detecting ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia Based on High-Throughput Sequencing Technology].
Zhongguo shi yan xue ye xue za zhi - 1 Feb 2024
Zhou Ling, Wang Jun-Liang, Wang Xian-Wei, Li Yang-Wei, Zou Zhe, Zhang Yan-Li, Lyu Xiao-Dong
Abstract excerpt
OBJECTIVE: To compare the efficacy and clinical value of high-throughput sequencing (HTS) and Sanger sequencing in detecting ABL kinase domain mutations in patients with chronic myeloid leukemia (CML). METHODS: A total of 198 samples of 147 CML patients from July 2017 to March 2021 in Henan Cancer Hospital were collected and underwent high-throughput sequencing and Sanger sequencing to detect the mutations in ABL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
